Olink

Olink®
Part of Thermo Fisher Scientific

Tissue and plasma proteomics for early stage cancer detection

Molecular Omics, 2018

Peng L., Cantor D., Huang C., Wang K., Baker M., Nice E.

Disease areaApplication areaSample typeProducts
Oncology
Review/editorial

Abstract

The pursuit of novel and effective biomarkers is essential in the struggle against cancer, which is a leading cause of mortality worldwide. Here we discuss the relative advantages and disadvantages of the most frequently used proteomics techniques, concentrating on the latest advances and application of tissue and plasma proteomics for novel cancer biomarker discovery.

Read publication ↗